EA200601176A1 - 3-цианохинолиновые производные с антипролиферативной активностью - Google Patents

3-цианохинолиновые производные с антипролиферативной активностью

Info

Publication number
EA200601176A1
EA200601176A1 EA200601176A EA200601176A EA200601176A1 EA 200601176 A1 EA200601176 A1 EA 200601176A1 EA 200601176 A EA200601176 A EA 200601176A EA 200601176 A EA200601176 A EA 200601176A EA 200601176 A1 EA200601176 A1 EA 200601176A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cyanohinoline
derivatives
antiproliferative activity
compounds
formula
Prior art date
Application number
EA200601176A
Other languages
English (en)
Inventor
Эдди Жан Эдгар Фрейн
Петер Якобус Йоханнес Антониус Бейнстерс
Кристоф Ван Эмелен
Вернер Констант Йохан Эмбрехтс
Тимоти Пьетро Сурен Перера
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684508&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200601176(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200601176A1 publication Critical patent/EA200601176A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems

Abstract

Настоящее изобретение относится к N-оксидным формам соединения формулы (I), их фармацевтически приемлемым солям и стереохимически изомерным формам. Соединения формулы (I) ингибируют тирозинкиназные ферменты.
EA200601176A 2003-12-18 2004-12-15 3-цианохинолиновые производные с антипролиферативной активностью EA200601176A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EPPCT/EP03/51059 2003-12-18
PCT/EP2004/053497 WO2005058318A1 (en) 2003-12-18 2004-12-15 3-cyano-quinoline derivatives with antiproliferative activity

Publications (1)

Publication Number Publication Date
EA200601176A1 true EA200601176A1 (ru) 2006-10-27

Family

ID=34684508

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200601176A EA200601176A1 (ru) 2003-12-18 2004-12-15 3-цианохинолиновые производные с антипролиферативной активностью

Country Status (23)

Country Link
US (4) US7655642B2 (ru)
EP (1) EP1696914B1 (ru)
JP (1) JP4892353B2 (ru)
KR (1) KR101158440B1 (ru)
CN (1) CN1893944B (ru)
AR (1) AR047060A1 (ru)
AT (1) ATE446750T1 (ru)
AU (1) AU2004298784B2 (ru)
BR (1) BRPI0417609B8 (ru)
CA (1) CA2549728C (ru)
DE (1) DE602004023876D1 (ru)
EA (1) EA200601176A1 (ru)
ES (1) ES2335216T3 (ru)
HK (1) HK1095742A1 (ru)
IL (1) IL176358A (ru)
MX (1) MXPA06007018A (ru)
NO (1) NO337622B1 (ru)
NZ (1) NZ547795A (ru)
SG (1) SG151288A1 (ru)
TW (2) TWI374879B (ru)
UA (1) UA83880C2 (ru)
WO (1) WO2005058318A1 (ru)
ZA (1) ZA200604971B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005058318A1 (en) * 2003-12-18 2005-06-30 Janssen Pharmaceutica N.V. 3-cyano-quinoline derivatives with antiproliferative activity
MXPA06007017A (es) 2003-12-18 2006-08-31 Janssen Pharmaceutica Nv Derivados de pirido y pirimidopirimidina como agentes antiproliferativos.
NI200700147A (es) 2004-12-08 2019-05-10 Janssen Pharmaceutica Nv Derivados de quinazolina inhibidores de cinasas dirigidos a multip
JO3088B1 (ar) * 2004-12-08 2017-03-15 Janssen Pharmaceutica Nv مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف
MY169441A (en) 2004-12-08 2019-04-11 Janssen Pharmaceutica Nv 2,4, (4,6) pyrimidine derivatives
US8143255B2 (en) 2005-11-16 2012-03-27 S*Bio Pte Ltd. Heteroalkyl linked pyrimidine derivatives
US10517876B2 (en) 2005-11-16 2019-12-31 Cti Biopharma Corp. Oxygen linked pyrimidine derivatives
WO2008006884A2 (en) 2006-07-13 2008-01-17 Janssen Pharmaceutica N.V. Mtki quinazoline derivatives
EP2123627B1 (en) * 2007-01-19 2013-11-20 Ube Industries, Ltd. Process for producing aromatic amine having aralkyloxy or heteroaralkyloxy group
DK2170827T3 (da) * 2007-06-21 2013-11-18 Janssen Pharmaceutica Nv Indolin-2-oner og aza-indolin-2-oner
DK2185562T3 (en) 2007-07-27 2016-02-22 Janssen Pharmaceutica Nv PYRROLOPYRIMIDINES SUITABLE FOR TREATING PROLIFERATIVE DISEASES
CN102127087B (zh) * 2011-01-21 2012-07-04 江苏先声药物研究有限公司 喹唑啉衍生物
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
AU2016333987A1 (en) 2015-10-05 2018-05-10 Ny State Psychiatric Institute Activators of autophagic flux and phospholipase D and clearance of protein aggregates including tau and treatment of proteinopathies

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028613A (en) 1990-02-16 1991-07-02 Repligen Corporation Novel pyrroloquinoline alkaloids and methods of use
US6002008A (en) 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
UA73073C2 (ru) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Замещенные 3-циан хинолины
AU763669B2 (en) * 1998-09-29 2003-07-31 Wyeth Holdings Corporation Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
US6288082B1 (en) 1998-09-29 2001-09-11 American Cyanamid Company Substituted 3-cyanoquinolines
EA009300B1 (ru) * 2002-03-30 2007-12-28 Бёрингер Ингельхайм Фарма Гмбх Унд Ко. Кг 4-(n-фениламино)хиназолины/-хинолины в качестве ингибиторов тирозинкиназы
PA8603801A1 (es) * 2003-05-27 2004-12-16 Janssen Pharmaceutica Nv Derivados de la quinazolina
WO2005058318A1 (en) * 2003-12-18 2005-06-30 Janssen Pharmaceutica N.V. 3-cyano-quinoline derivatives with antiproliferative activity

Also Published As

Publication number Publication date
NO337622B1 (no) 2016-05-09
ATE446750T1 (de) 2009-11-15
US8778920B2 (en) 2014-07-15
US7655642B2 (en) 2010-02-02
US20080139601A1 (en) 2008-06-12
BRPI0417609A (pt) 2007-04-10
CN1893944B (zh) 2011-07-06
KR20070005560A (ko) 2007-01-10
NO20063324L (no) 2006-07-18
CA2549728C (en) 2015-07-21
HK1095742A1 (en) 2007-05-18
JP2007514711A (ja) 2007-06-07
US9040511B2 (en) 2015-05-26
KR101158440B1 (ko) 2012-07-06
CA2549728A1 (en) 2005-06-30
NZ547795A (en) 2009-07-31
BRPI0417609B8 (pt) 2021-05-25
TWI374879B (en) 2012-10-21
IL176358A0 (en) 2006-10-05
JP4892353B2 (ja) 2012-03-07
AU2004298784A1 (en) 2005-06-30
UA83880C2 (en) 2008-08-26
TW201132628A (en) 2011-10-01
EP1696914B1 (en) 2009-10-28
TWI389890B (zh) 2013-03-21
EP1696914A1 (en) 2006-09-06
WO2005058318A1 (en) 2005-06-30
TW200530187A (en) 2005-09-16
DE602004023876D1 (de) 2009-12-10
US20100069424A1 (en) 2010-03-18
ZA200604971B (en) 2009-05-27
MXPA06007018A (es) 2006-08-31
SG151288A1 (en) 2009-04-30
US20140256948A1 (en) 2014-09-11
AR047060A1 (es) 2006-01-04
US9365517B2 (en) 2016-06-14
AU2004298784B2 (en) 2011-06-09
ES2335216T3 (es) 2010-03-23
CN1893944A (zh) 2007-01-10
BRPI0417609B1 (pt) 2019-02-19
US20130197022A1 (en) 2013-08-01
IL176358A (en) 2010-06-16

Similar Documents

Publication Publication Date Title
NO20063324L (no) 3-cyano-kinolinderivater med antiproliferativ aktivitet
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
EA200500721A1 (ru) Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств
NO20070514L (no) Pyrrolotriazin kinase inhibitorer
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
EA200700633A1 (ru) Производные замещённого анилина
EA200700220A1 (ru) Имидазотриазины в качестве ингибиторов протеинкиназы
DK1474395T3 (da) Nicotinamidderivater, der er nyttige som p38-inhibitorer
EA200801291A1 (ru) Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ
NO20070529L (no) Kinazolindionderivater som parp-inhibitorer
DE60316013D1 (de) Heteroaryl-pyrimidinderivate als jak-inhibitoren
NO20062763L (no) Pyrrolotriazinforbindelser som kinaseinhibitorer
DE60309848D1 (de) Purinderivate als kinaseinhibitoren
ATE517896T1 (de) P38-kinase-inhibitoren
ATE405266T1 (de) Monozyklische oder bizyklische carbozyklen und heterozyklen als hemmer von factor xa
AU2003226572A1 (en) Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
CR9929A (es) Nuevos compuestos
SE0202463D0 (sv) Novel compounds
DK1771178T3 (da) Anvendelse af K-252A og kinaseinhibitorer til forebyggelse eller behandling af HMGB1-assocuerede patologiske tilstande
EA200801199A1 (ru) Ингибиторы киназы
ATE482212T1 (de) Pyrrolotriazinverbindungen
EA200801200A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛИЗОХИНОЛИНМОЧЕВИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ p38 КИНАЗЫ
ATE468341T1 (de) Thienopyrazole
TW200628153A (en) Novel compounds
MXPA05009282A (es) Derivados de anilina sustituidos.